Imagen de Portada

Development of a mass spectrometry-based method for quantification of Ustekinumab in serum specimens

Background:Ustekinumab (UST) is a human monoclonal antibody used to treat moderate-to-severe Crohn disease by blocking the interleukin-12/23 pathway....

Guardado en:
Detalles Bibliográficos
Autores principales: Gerhardt, Nina (Autor) , Schreiner, Rupert (Autor) , Thomann, Anne K. (Autor) , Findeisen, Peter (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: August 2020
In: Therapeutic drug monitoring
Year: 2020, Volumen: 42, Número: 4, Pages: 572-577
ISSN:1536-3694
DOI:10.1097/FTD.0000000000000734
Acceso en línea:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/FTD.0000000000000734
Verlag, lizenzpflichtig, Volltext: https://www.ovid.com/jnls/drug-monitoring/fulltext/10.1097/ftd.0000000000000734~development-of-a-mass-spectrometry-based-method-for
Enlace del recurso
Notas de Autor:Nina Scheffe, Rupert Schreiner, Anne Thomann, Peter Findeisen
Descripción
Sumario:Background:Ustekinumab (UST) is a human monoclonal antibody used to treat moderate-to-severe Crohn disease by blocking the interleukin-12/23 pathway....
Notas:Gesehen am 11.08.2026
Descripción Física:Online Resource
ISSN:1536-3694
DOI:10.1097/FTD.0000000000000734

Ejemplares similares